Laurus Labs Limited
NSE: LAURUSLABS
About Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Summary as recorded on Thu, 03 Sept, 2026.
Results
No scheduled results found for LAURUSLABS.
Historical quarterly results aren't available in the current data feed.
Corporate Actions
No recent corporate actions for LAURUSLABS.
Latest News · Laurus Labs Limited
Company overview assembled from NSE results / corporate-action feeds and market news. Not investment advice.

